Dr Frederick A Depaola, MD | |
2444 Highway 34, Manasquan, NJ 08736-1808 | |
(732) 528-4370 | |
(732) 528-4525 |
Full Name | Dr Frederick A Depaola |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 35 Years |
Location | 2444 Highway 34, Manasquan, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538156815 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | MA045796 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hackensack Meridian Health At Home Monmouth County | Neptune, NJ | Home health agency |
Hackensack Meridian Health At Home Ocean County | Brick, NJ | Home health agency |
Jersey Shore University Medical Center | Neptune, NJ | Hospital |
Ocean Medical Center | Brick, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ea Health - New Jersey Llc | 6103222039 | 22 |
Seaview Orthopaedics And Medical Associates Llp | 7810983210 | 86 |
News Archive
The first view of the physical mechanism of how a blood clot contracts at the level of individual platelets is giving researchers from the Perelman School of Medicine at the University of Pennsylvania a new look at a natural process that is part of blood clotting.
Pfizer Inc. announced today that a Phase 3 study of INLYTA (axitinib) did not meet its primary endpoint of demonstrating statistically significantly longer progression-free survival, versus sorafenib, in treatment-naïve patients with advanced renal cell carcinoma.
PharmAthene, Inc., a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that pursuant to the Federal Acquisition Regulations and pending a ruling in a protest recently filed by a competitor the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), has suspended work under the modification the Company announced on February 23, 2010 to its existing contract with BARDA for the research and development of SparVax™. June 11, 2010 is the deadline to rule on the protest.
Lead is a toxic metal, and its widespread use has led to significant environmental pollution and public health problems in many parts of the world.
› Verified 7 days ago
Entity Name | Seaview Orthopaedics & Medical Associates Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1982618757 PECOS PAC ID: 7810983210 Enrollment ID: O20040421001657 |
News Archive
The first view of the physical mechanism of how a blood clot contracts at the level of individual platelets is giving researchers from the Perelman School of Medicine at the University of Pennsylvania a new look at a natural process that is part of blood clotting.
Pfizer Inc. announced today that a Phase 3 study of INLYTA (axitinib) did not meet its primary endpoint of demonstrating statistically significantly longer progression-free survival, versus sorafenib, in treatment-naïve patients with advanced renal cell carcinoma.
PharmAthene, Inc., a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that pursuant to the Federal Acquisition Regulations and pending a ruling in a protest recently filed by a competitor the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), has suspended work under the modification the Company announced on February 23, 2010 to its existing contract with BARDA for the research and development of SparVax™. June 11, 2010 is the deadline to rule on the protest.
Lead is a toxic metal, and its widespread use has led to significant environmental pollution and public health problems in many parts of the world.
› Verified 7 days ago
Entity Name | Ea Health - New Jersey Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063186641 PECOS PAC ID: 6103222039 Enrollment ID: O20210901001290 |
News Archive
The first view of the physical mechanism of how a blood clot contracts at the level of individual platelets is giving researchers from the Perelman School of Medicine at the University of Pennsylvania a new look at a natural process that is part of blood clotting.
Pfizer Inc. announced today that a Phase 3 study of INLYTA (axitinib) did not meet its primary endpoint of demonstrating statistically significantly longer progression-free survival, versus sorafenib, in treatment-naïve patients with advanced renal cell carcinoma.
PharmAthene, Inc., a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that pursuant to the Federal Acquisition Regulations and pending a ruling in a protest recently filed by a competitor the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), has suspended work under the modification the Company announced on February 23, 2010 to its existing contract with BARDA for the research and development of SparVax™. June 11, 2010 is the deadline to rule on the protest.
Lead is a toxic metal, and its widespread use has led to significant environmental pollution and public health problems in many parts of the world.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Frederick A Depaola, MD 2444 Highway 34, Manasquan, NJ 08736-1808 Ph: (732) 528-4370 | Dr Frederick A Depaola, MD 2444 Highway 34, Manasquan, NJ 08736-1808 Ph: (732) 528-4370 |
News Archive
The first view of the physical mechanism of how a blood clot contracts at the level of individual platelets is giving researchers from the Perelman School of Medicine at the University of Pennsylvania a new look at a natural process that is part of blood clotting.
Pfizer Inc. announced today that a Phase 3 study of INLYTA (axitinib) did not meet its primary endpoint of demonstrating statistically significantly longer progression-free survival, versus sorafenib, in treatment-naïve patients with advanced renal cell carcinoma.
PharmAthene, Inc., a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that pursuant to the Federal Acquisition Regulations and pending a ruling in a protest recently filed by a competitor the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), has suspended work under the modification the Company announced on February 23, 2010 to its existing contract with BARDA for the research and development of SparVax™. June 11, 2010 is the deadline to rule on the protest.
Lead is a toxic metal, and its widespread use has led to significant environmental pollution and public health problems in many parts of the world.
› Verified 7 days ago
Mark M Seckler, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2444 Highway 34, Manasquan, NJ 08736 Phone: 732-528-4370 Fax: 732-528-4525 | |
Ahmed Siddiqi, D.O Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2315 Route 34, Manasquan, NJ 08736 Phone: 732-974-0404 Fax: 732-449-4271 | |
Dr. John M Tozzi, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2315 Rt 34 So, Ste D, Manasquan, NJ 08736 Phone: 732-974-0404 Fax: 732-449-4271 | |
Dr. Clint C Ferenz, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2315 Rt 34 So, Ste D, Manasquan, NJ 08736 Phone: 732-974-0404 Fax: 732-449-4271 | |
Dr. Ramil S Bhatnagar, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2315 Rt 34 So, Ste D, Manasquan, NJ 08736 Phone: 732-974-0404 Fax: 732-449-4271 | |
Dr. Nicholas Albert Jarmon, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2315 Route 34, Manasquan, NJ 08736 Phone: 732-974-0404 | |
Dr. Michael A Sclafani, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2315 Rt 35 So, Ste D, Manasquan, NJ 08736 Phone: 732-974-0404 Fax: 732-449-4271 |